Form 4: Palisade Bio Director Acquires Shares Through Restricted Stock Unit Vesting

Director Donald Allen Williams acquired 340 shares of Palisade Bio, Inc. common stock due to the vesting and settlement of restricted stock units.

Summary

• On June 11, 2024, Donald Allen Williams, a director of Palisade Bio, Inc., acquired 340 shares of common stock.
• The acquisition resulted from the vesting and settlement of restricted stock units (RSUs) granted on June 11, 2023.
• The price per share for the RSU settlement was $0.00.
• Following the transaction, Williams directly owns 340 shares of common stock and indirectly owns 3,000 shares through a defined benefit plan.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock ownership. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider transactions.

Positives

• The vesting of restricted stock units suggests that the director is aligned with the company's long-term performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide investors with insights into the actions of company insiders, such as directors and officers.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding the director's stock ownership.

Key Dates

Keywords

Palisade Bio, Director, Donald Allen Williams, Stock Acquisition, Restricted Stock Units, RSU, Beneficial Ownership, Form 4